“Nanolek” released the first batch of hydroxychloroquine

The company “Nanolek” factory in the Kirov region has established the production of one of the drugs for the treatment of coronavirus infection of hydroxychloroquine. Currently, hydroxychloroquine is included in the treatment protocols in the interim Ministry of health recommendations for the prevention, diagnosis and treatment of new coronavirus infection.

The first batch of this drug was shipped to medical institutions in various regions of the Russian Federation.

“We hope that the release of the drug in our production will reduce the deficit and to cover the demand for this drug, because it retains the need for patients suffering from malaria and rheumatoid arthritis who are on therapy with this drug for many years”, – said Mikhail Nekrasov, CEO of NANOLEK. Nekrasov explained that “Nanolek” started the development of hydroxychloroquine in 2013 in conjunction with the company “BIOCOM” in the framework of the state contract.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]